[Federal Register Volume 64, Number 104 (Tuesday, June 1, 1999)]
[Notices]
[Page 29358]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-13830]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated December 14, 1998, and published in the Federal
Register on December 28, 1998, (63 FR 71156), Eli-Elsohly Laboratories,
Inc., Mahmoud A. Elsohly, PhD, 5 Industrial Park Drive, Oxford,
Mississippi 38655, made application by renewal to the Drug Enforcement
Administration (DEA) for registration as a bulk manufacturer of the
basic classes of controlled substances listed below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)............... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Benzoylecgonine (9180)..................... II
Hydrocodone (9193)......................... II
------------------------------------------------------------------------
The firm plans to bulk manufacture non-deuterated controlled
substances for use as analytical standards and deuterated controlled
substances for use as internal standards.
DEA has considered the factors in Title 21, United States Code,
Section 823(a) and determined that the registration of Eli-Elsohy
Laboratories, Inc. to manufacture the listed controlled substance is
consistent with the public interest at this time. DEA has investigated
Eli-Elsohly Laboratories, Inc. on a regular basis to ensure that the
company's continued registration is consistent with the public
interest. These investigations have included inspection and testing of
the company's physical security systems, audits of the company's
records, verification of the company's compliance with state and local
laws, and a review of the company's background and history. Therefore,
pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy
Assistant Administrator, Office of Diversion Control, hereby orders
that the application submitted by the above firm for registration as a
bulk manufacturer of the basic class of controlled substance listed
above is granted.
Dated: May 19, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 99-13830 Filed 5-28-99; 8:45 am]
BILLING CODE 4410-09-M
